CLEAR SYNERGY (OASIS 9)

Sanjit Jolly

Scientist

Sanjit Jolly is an interventional cardiologist at Hamilton Health Sciences and associate professor at McMaster University. He has formal training in clinical trials with a M.Sc. in Health Research Methodology from McMaster. He was the principal investigator of the RIVAL trial, a randomized trial of 7021 patients comparing radial and femoral access for coronary intervention. He is also the principal investigator trial of the ongoing TOTAL trial, an international randomized trial (N=10,700) of thrombectomy during primary PCI.

Marc-André d’Entremont

Research Fellow

Marc-André d’Entremont is a Research Fellow at PHRI, supervised by Sanjit Jolly, and a Ph.D. candidate in the Health Research Methodology program at McMaster University under the supervision of Sanjit Jolly, Émilie Belley-Côté and Richard Whitlock.

A Clinical Scholar in the Division of Cardiology at McMaster, he has been awarded a CIHR Canada Graduate Scholarship Doctoral Award. His research interests include coronary artery disease therapeutics, intravascular imaging, and clinical trial methodology.

He obtained his M.D. at the Université de Sherbrooke in 2015 and completed his internal medicine and cardiology residency at the same institution. During his residency, he completed a Master of Public Health at Harvard University in 2021.

Jessica Tyrwhitt

Program Manager

Jessica Tyrwhitt has more than 10 years’ experience in coordinating and managing large, international clinical trials. She oversees interventional trials, registries, and observational research studies looking at primary and secondary prevention of cardiovascular disease in a variety of therapeutic areas, including cardiology, thrombosis, nephrology, cardio-oncology and diabetes.

She holds an Honours Bachelor of Science Degree & Business from the University of Waterloo.